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Abstract
The effects of ethylene oxide and propylene oxide block copolymers (pluronics) on the permeability of several weak acids
and bases through bilayer lipid membranes have been studied by the methods of monitoring (1) pH shifts near planar
bilayers, (2) doxorubicin fluorescence quenching inside liposomes, and (3) current transients in the presence of hydrophobic
anions. It has been shown that pluronics facilitate the permeation of comparatively large molecules (such as 2-n-
undecylmalonic acid and doxorubicin) across lipid bilayers, while the permeation of small solutes (such as ammonium and
acetic acid) remains unaffected. Pluronics also accelerate the translocation of large hydrophobic anions (tetraphenylborate).
The effect of pluronics correlates with the content of propylene oxide units : it is enhanced when the portion of polypropylene
oxide block in the copolymer is increased. The action of the pluronic on lipid membrane permeability differs from the effect
of the conventional detergent Triton X-100, which does not affect doxorubicin transport if added at concentrations similar to
those used for pluronics. It has been proposed that pluronics accelerate the processes of solute diffusion within lipid bilayers
(in a structure-dependent manner) rather than influencing the rate of solute adsorption/desorption on the membrane surface.
We suppose that the effect of pluronics on doxorubicin permeation across lipid bilayers along with the known effect on the
multidrug resistance protein determines its influence on the therapeutic activity of anthracycline drugs. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
The crucial role of biological membranes consists
in the creation of the permeability barrier for cellular
components. For certain medical and research pur-
poses, it is important to ¢nd compounds that can
break this barrier. These compounds, called perme-
abilizers, are used e.g. for the release of certain sub-
stances and for the study of the metabolism of the
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inner cellular components at the level of whole cells
[1^3]. Conventional common permeabilizers, such as
digitonin and alamethicin, provoke the formation of
aqueous pores in membranes inducing their perme-
ability to low molecular weight metabolites [4,5].
Ethylene oxide and propylene oxide block copoly-
mers (pluronics) with the common formula
are widely used in medicine and biotechnology as
biocompatible surfactants. Pluronic F-68 has been
reported to inhibit thrombosis, decrease whole blood
viscosity, and improve perfusion of damaged tissue
[6,7]. In a series of research works pluronic copoly-
mers have been tested as emulsi¢ers for per£uorocar-
bons used in arti¢cial blood compositions [8^10] and
as immunoadjuvants [11,12]. Medical applications of
pluronic copolymers are connected mainly with their
ability to increase the permeability of biological
membranes to di¡erent substances. These copoly-
mers promote transdermal delivery of peptides
[13,14] and low molecular weight drugs [15,16], facil-
itate delivery of drugs across the blood^brain barrier
[17], and contribute to the loading of cells with £uo-
rescent dyes [18] or ATP [19]. Pluronic copolymers
have been reported to potentiate therapeutic activity
of antitumor drugs [20,21]. Moreover, pluronic co-
polymer^doxorubicin compositions have been
proved to be e¡ective for the treatment of multi-
drug-resistant tumors not only in vitro, but also in
vivo [21^23].
A number of research works concerned the inter-
action of pluronics with lipid membranes. Changes in
the phase properties of lipid bilayers were observed
using calorimetric approaches [24]. It has been shown
also that adsorption of pluronics onto liposome sur-
faces results in an increase of the liposome hydro-
dynamic size and a reduction of the j-potential
[25]. The interaction of pluronic F-108 with the sur-
face of liposomes promotes the leakage of radioac-
tive or £uorescent probes incorporated in liposomes
[26,27]. Nevertheless, polymer concentrations and ex-
perimental conditions in the above mentioned papers
are far from those used in biological experiments,
and it is still unclear whether the in£uence of plur-
onics on cell membrane permeability is mediated by
their interaction with a lipid part of the cell mem-
branes. Moreover, there are still no data concerning
the mechanism of the pluronic e¡ect on cell mem-
brane permeability.
Two di¡erent mechanisms have been proposed to
account for the solute permeation across lipid mem-
branes, namely (i) the di¡usion through transient
pores or defects in the membrane, and (ii) partition-
ing into the hydrophobic phase of the bilayer fol-
lowed by di¡usion to the opposite side of the mem-
brane [28,29]. The mechanism of the permeation of
ions as well as of some small solutes depends on the
structure and composition of lipid membranes; in
particular in the case of short-chain lipids, it is con-
sistent with the transient pore model [30,31]. On the
other hand, the permeation of the majority of solutes
across bilayers correlates well with membrane parti-
tioning and can be characterized by the solubility^
di¡usion mechanism [28,29,32]. Permeation across
bilayer membranes is dependent on the size and the
shape of a solute molecule [33,34] as well as on mem-
brane viscosity [35].
Planar bilayer lipid membranes (BLMs) and uni-
lamellar liposomes have been used in the present
work for the investigation of the e¡ect of pluronics
on the permeability of several solutes across lipid
membranes. The permeation of weak acids and bases
through a planar BLM has been measured by a tech-
nique developed in our laboratory which is based on
the monitoring of steady-state pH shifts in the un-
stirred layers (USLs) near the BLM [36^39]. Trans-
port of doxorubicin, the powerful anticancer drug,
across membranes of liposomes has been studied by
measuring the changes in £uorescence intensity as
proposed by Harrigan et al. [40]. It has been found
that pluronics facilitate the permeation of solutes
across lipid bilayers, the e¡ect being dependent on
the chemical nature of the compound.
2. Materials and methods
2.1. Materials
Block copolymers of ethylene oxide and propylene
oxide (pluronics P85, L61 and F68) and Triton X-
100 were from Serva (Heidelberg, Germany). Doxo-
rubicin hydrochloride (95% purity according to liq-
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uid chromatography) was purchased from the Rus-
sian Antibiotic Institute. Bu¡er components were
from Sigma (St. Louis, MO, USA). 2-n-Undecylma-
lonic acid (K,K-DC11) was a generous gift of Dr. D.
Bondarenko from the A.N. Bakh Institute of Bio-
chemistry, Russian Academy of Science; it was pre-
pared by alkylation of diethyl malonate with n-un-
decylbromide [39]. Synthesized K,K-DC11 contained
98% of the basic compound according to gas chro-
matography of its dimethyl esters. Ammonium chlo-
ride, acetic acid and tetraphenylborate (TPB) were
from Sigma (St. Louis, MO, USA). Tetra£uorotri-
chlorobenzimidazole (TTFB) was a gift of Prof.
E.A. Liberman.
2.2. Methods
2.2.1. Measurement of £uxes of weak acids and bases
across planar lipid membranes
BLMs were formed by a conventional method [41]
in a hole, 0.4 mm in diameter, of a diaphragm divid-
ing a PTFE chamber. The membrane forming solu-
tion contained 20 mg diphytanoyl phosphatidylcho-
line (Avanti Polar Lipids, Alabaster, AL, USA) in
1 ml of n-decane (Merck, Darmstadt, Germany).
The electrical resistance of the BLM was measured
with the help of an OES-2 patch-clamp ampli¢er
(Opus, Moscow, Russia). Gradients on the BLM
(vpHs) were measured according to Antonenko et
al. [36,42] by the method of recording an open-circuit
potential in the presence of a protonophore (10 WM
TTFB) which was added on both sides of the BLM.
The potential had a plus sign on the side of the
membrane where the acid was added. The experi-
ments were carried out at room temperature (21^
23‡C).
JH were estimated from the following equation
[43]
JH  DbuffBvpH2N 1
where Dbuff is the di¡usion coe⁄cient of the bu¡er
molecules, B is the bu¡er capacity of the solutions,
vpH is the pH gradient on the BLM, and N is the
thickness of the unstirred layer. We used values for
Dbuff of 5U1036 cm2/s and for N of 200 Wm following
Antonenko et al. [37]. vpHs were calculated from the
values of protonophore-dependent potentials accord-
ing to the Nernst equation [36].
pH shifts in the USLs near the BLM were meas-
ured directly by means of an antimony pH micro-
electrode according to Evtodienko et al. [39]. It
should be noted that the sum of two pH shifts on
the opposite sides of the BLM is equal to the vpH
gradient on BLM. It has been shown previously that
the two methods of pH shift measurement give con-
sistent results [42]. Typically, the electrode tip was
10 Wm in our experiments. A smooth approach to
the membrane was carried out by means of a hy-
draulic microdrive.
2.2.2. TPB3 current relaxation experiments
The electric current (I) was recorded under volt-
age-clamp conditions by application of a step of the
potential (voltage jump) [44]. The current was meas-
ured by means of a U5-11 ampli¢er (Moscow, Rus-
sia), digitized by DT2814 (Data Translation, Marl-
boro, MA, USA) and analyzed by a personal
computer. Ag/AgCl electrodes were placed directly
into the cell, in most experiments a voltage of
100 mV was applied to the BLM.
The conductivity of the unmodi¢ed BLM was es-
timated from the electrical current at a given voltage
(50 mV). The water solution in both compartments
of the experimental chamber contained 10 mM MES,
10 mM Tris, and 100 mM choline chloride, pH 6.4.
2.2.3. Preparation of liposomes
Unilamellar liposomes were prepared according to
Yaroslavov et al. [45]. A phosphatidylcholine ethanol
solution (20 mg, Kharkov Bacterial Preparations
Company, Ukraine) was carefully evaporated under
vacuum. The thin layer of the lipid mixture was dis-
persed in 0.3 M citrate^Tris bu¡er, pH 4.0, with a
Cole-Parmer 4700 ultrasonic homogenizer. Liposome
samples thus obtained were separated from the tita-
nium dust by centrifugation and used during 1 day.
The diameter of liposomes measured by quasi-elastic
light scattering was in the range of 50^70 nm. To
replace the external solution, 1 ml of the liposome
suspension was added to the Sepharose CL-4B col-
umn equilibrated with 20 mM HEPES^Tris bu¡er
pH 7.0 supplemented with 0.3 M sucrose to avoid
osmotic swelling of vesicles.
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2.2.4. Kinetics of the in£ux of doxorubicin into
liposomes
The kinetics of the doxorubicin pH-induced up-
take by liposomes was measured according to Harri-
gan et al. [40] and Maurer-Spurej et al. [46]. Doxor-
ubicin (0.1 mM) or its mixture with pluronic was
added to liposomes ¢lled with 0.3 M citrate bu¡er
pH 4.0, and changes in £uorescence intensity at
557 nm were monitored with a Hitachi F-3000 spec-
tro£uorometer, using an excitation wavelength of
490 nm. Accumulation of doxorubicin in the lipo-
some interior resulted in a 100^1000-fold increase
in its local concentration accompanied by a fast de-
crease in £uorescence. The rate constant of drug up-
take at 30‡C was calculated from the kinetics of £uo-
rescence intensity lowering using a ¢rst order model.
As has been shown by Harrigan et al. [40], the rate
constant k in this case depends upon the pH gradient
(vpH), the liposome surface area (A), the permeabil-
ity coe⁄cient (P), the external aqueous volume Vo,
the apparent membrane^water partition coe⁄cient of
the charged form of the drug K*, the dissociation
constant of the drug Ka and the external proton con-
centration [H] :
k  PAK
Ka
VoH 2
Acceleration of the doxorubicin in£ux into liposomes
was calculated as the ratio of the rate constant in the
presence of pluronic to that measured without plur-
onic for liposomes prepared in the same series, the
liposome concentration was the same for both sam-
ples.
3. Results
3.1. E¡ect of pluronic copolymers on the electric
conductance of BLM
One of the advantages of the planar bilayer system
consists in the possibility of studying both electro-
genic and electrically silent solute £uxes. A series of
measurements showed that the addition of pluronics
(P85 and L61) alone or in combination with weak
acids or bases did not increase the electrical conduc-
tance of the BLM which remained within 10 nS/cm2
under our experimental conditions. These measure-
ments give the upper limit of the electrogenic solute
£uxes that can arise in our system. In fact, a con-
ductivity of 10 nS/cm2 corresponds to a £ux of a
solute carrying a single charge of 2U10315 mol of
charges/cm2 s [47] :
JS  RTtS
Gm
z2SF
2
3
where Gm is the membrane conductance, tS is the
transference number for ions (1.0 in our estimation),
R is the gas constant, T is the absolute temperature,
zS is the ionic valence and F is the Faraday con-
stant. Since a typical value of a solute £ux measured
in our system was about 10311 mol/cm2 s (see below),
it can be concluded that the £uxes across the BLM
under our experimental conditions were electrically
silent.
It is noteworthy, however, that the addition of
potassium ions in the solutions bathing the mem-
brane resulted in the induction of the pluronic-medi-
ated electrical conductance of the BLM. Since this
e¡ect is beyond the scope of the present research, we
did not study it in detail. None of the bu¡er solu-
tions used here contained potassium ions.
3.2. E¡ect of pluronic copolymers on the transport of
K,K-DC11 across planar lipid membranes
The permeation of weak acids across planar mem-
branes was studied using a technique based on mea-
suring the pH shifts in the vicinity of the membrane.
This method allows us to measure the £uxes of neu-
tral forms of these substances across the BLM. Per-
meation of neutral forms of weak bases and acids
across lipid bilayers is accompanied by the formation
of pH gradients in the vicinity of the membrane due
to the dissociation^association processes occurring in
the USL near the BLM. It has been shown in our
previous works that the transmembrane £ux of a
neutral form of a solute can be calculated from the
pH gradient according to Eq. 1. pH gradients were
calculated from the values of the transmembrane po-
tential (vP) formed on the BLM in the presence of
the protonophore TTFB. The Nernst equation gives
the linear dependence between the transmembrane
potential and the pH gradient with a coe⁄cient of
58 mV at 25‡C.
Fig. 1A shows a typical curve of generation of the
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transmembrane potential in response to the addition
of K,K-DC11 into one of the compartments of the
experimental cell. The addition of P85 pluronic co-
polymer into both compartments led to a six-fold
increase in the transmembrane potential correspond-
ing to a six-fold increase in the solute £ux across the
BLM (from 1.6U10312 to 9.1U10312 mol H/cm2 s).
The L61 pluronic e¡ect on the bilayer permeability
increased upon raising the copolymer concentration
(Fig. 1B).
These results were con¢rmed by direct measure-
ments of pH shifts on both sides of the BLM, per-
formed in the absence of TTFB with the help of the
pH microelectrode. Fig. 2, curve 1, demonstrates the
formation of the pH pro¢le on the cis side of the
BLM (the side where the acid has been added) after
the addition of 100 WM K,K-DC11 under conditions
identical to those of the experiment shown in Fig.
1A. The permeation of the acid leads to a pH in-
crease near the cis side of the membrane surface re-
£ecting the disappearance of protons due to acid
permeation through the membrane in symport with
protons. In agreement with the results of the mea-
surements of protonophore-dependent potentials, the
addition of the copolymer to both compartments of
the cell led to a drastic increase in the pH shift near
the membrane surface (Fig. 2, curve 2). Since the
addition of pluronics does not a¡ect the membrane
conductivity, the proton £uxes induced by weak
bases and acids across the BLM in the presence of
pluronics are electrically silent and proceed via the
symport with the acid.
So, it may be concluded that pluronic copolymers
considerably increase the permeability of the BLM to
the neutral form of K,K-DC11. Taking into account
Fig. 2. E¡ect of P85 pluronic copolymer on the £ux of K,K-
DC11 across the planar bilayer measured by the recording of
pH pro¢les near the BLM (at x = 0) by pH microelectrode on
the cis side of the membrane (where the acid is added). The
concentration of K,K-DC11 on the cis side is 100 WM, [P85] is
2U1032% on both sides of the BLM. Other conditions are the
same as in Fig. 1. The solution is without TTFB.
Fig. 1. (A) E¡ect of P85 pluronic copolymer on the £ux of
K,K-DC11 across the planar bilayer measured by recording the
transmembrane vpH. The concentration of K,K-DC11 on the
cis side is 100 WM, [P85] is 2U1032% on both sides of the
BLM. The solution is 1 mM Tris, 1 mM MES, 100 mM cho-
line chloride, 10 WM TTFB, pH 6.2. (B) E¡ect of the concen-
tration of L61 pluronic copolymer on the ratio of the K,K-
DC11 £uxes in the presence of the pluronic and in the control.
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that pluronic copolymers are micelle-forming surfac-
tants, one can suppose that their in£uence on BLM
permeability is caused by the solubilization of the
substances in micelles, which in turn fuse with the
bilayer. This explanation seems unlikely, because
the experimental conditions (21‡C, 1^2U1032% of
pluronic) are unfavorable for micelle formation.
The critical micellization concentration (CMC) has
been reported to be about 5% at 20‡C (Table 1). It
may be proposed that the in£uence of pluronic co-
polymers on carboxylic acid permeation across the
BLM is due to its interaction with the membrane.
The results of the following experiments favor this
proposal. Fig. 3 shows the BLM transmembrane po-
tential generation in the presence of K,K-DC11, when
pluronic was added initially on the trans side of the
membrane (panel A) and on the cis side (panel B),
respectively. In the second case K,K-DC11 and the
pluronic can easily interact in the solution, whereas
in the ¢rst type of experiment this interaction is vir-
tually excluded. It is seen that the addition of plur-
onic P85 on the trans side of BLM resulted in even
bigger changes of K,K-DC11 £ux than when it was
added on the cis side. Thus, the solubilization of the
solute in micelles of pluronics cannot be responsible
for the e¡ect on the transmembrane £ux.
The transfer of weak acids across planar lipid bi-
layers can be limited either by di¡usion of the neutral
form of the solute across the membrane, or by the
di¡usion of the ionic form across the unstirred layer
Fig. 3. E¡ect of P85 pluronic copolymer added on di¡erent
sides of the membrane on the £ux of K,K-DC11 across the pla-
nar bilayer measured by the recording of transmembrane vpH.
The conditions are the same as in Fig. 1.
Table 1
E¡ect of di¡erent pluronic copolymers on the lipid bilayer per-
meability, composition, CMC and therapeutic activity
Copolymera Triton X-100
L61 P85 F68
Number of PEO units (n) 4 50 160 10
Number of PPO units (m) 30 40 30 ^
Molecular weight 2090 4500 8800 642
E¡ect on the translocation
rate constant of TPB3
with respect to control,
copolymer concentration
2U1034%
5.0 4.0 1.8 1.6
E¡ect on pH-induced
doxorubicin uptake into
liposomes with respect to
control, copolymer con-
centration 2U1033%
3.2 1.6 1.05 1.3
CMC (%)b 25‡C 0.01 5 ^ 0.016c
37‡C 0.0005 0.003
Optimal therapeutic con-
centration (g/kg body
weight)d
0.025 0.1 1.0 ^
aFor formula see Section 1.
b[23,52].
c[21].
d[61].
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near the membrane [39]. The relative contribution of
these processes depends on the ratio of ionic and
nonionic forms of the solute determined by its pKa
and pH of the solution. In order to rule out the
possibility that the e¡ect of pluronic corresponds to
the di¡usion of the anionic form of K,K-DC11 across
the unstirred layers, we studied the pH dependence
of the £ux of the acid. Provided that pluronic mainly
a¡ects the permeation of the neutral form of the
solute across the BLM and does not in£uence its
di¡usion through the USL, the e¡ect should be ob-
served only under alkaline conditions. Fig. 4 shows
the e¡ect of pluronic P85 on the value of the BLM
potential generated upon the addition of K,K-DC11
under acidic (panel A) and more alkaline (panel B)
conditions. Pluronic had no e¡ect on carboxylic acid
transport at acidic pH, showing that the copolymer
a¡ects the permeation of the neutral form of carbox-
ylic acid across the lipid bilayer.
3.3. E¡ect of pluronic copolymers on the transport of
small weak acids and bases across BLM
Fig. 5 shows the e¡ect of L61 pluronic copolymer
on the protonophore-dependent BLM potential gen-
erated as a result of the permeation of acetic acid
(panel A) and ammonia (panel B) across the mem-
brane. The experiments were carried out under con-
ditions where the transport was limited by the di¡u-
sion across the lipid phase and the contribution of
the di¡usion across the USLs was negligible. L61
pluronic had only a minor e¡ect on the acetic acid
and ammonia £uxes across the BLM. This ¢nding
shows that the e¡ect of pluronic copolymers on the
permeation of solutes is very sensitive to the nature
of the solute. On the other hand, these experiments
con¢rm that the e¡ect of the copolymers on mem-
brane permeability is not mediated by the formation
of pores in the lipid membrane, since small molecules
of acetic acid (or ammonia) would penetrate through
such pores more readily than large molecules of K,K-
DC11.
In the experiments with ammonia and acetate the
values of the potentials were close to those measured
with K,K-DC11 (about 2 mV). This means that the
transmembrane £uxes of the neutral forms of these
substances were close to each other since the experi-
ments were carried out under conditions where the
transport was limited by the di¡usion across the
BLM and the contribution of the di¡usion across
the USLs was negligible. This was achieved by ad-
justing the pH of the solution to substantially higher
(or lower for ammonia) values than the pKa so that
the pH decrease led to a concomitant decrease of the
value of protonophore-dependent potentials. How-
ever, the values of membrane permeabilities for small
solutes and K,K-DC11 di¡er considerably. In view of
this, the selectivity of the action of pluronic copoly-
mers may be accounted for by the di¡erences in per-
meability. It may be proposed that the e¡ect of co-
Fig. 4. E¡ect of P85 pluronic copolymer on the £ux of K,K-
DC11 across the planar bilayer measured at di¡erent pHs of
the solutions bathing the membrane by the recording of trans-
membrane vpH. (A) pH 3.8. (B) pH 6.3. The conditions are
the same as in Fig. 1.
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polymers is more pronounced for substances which
have a lower membrane permeability. In particular,
as described in Section 3.4, pluronics considerably
accelerate doxorubicin permeation through mem-
branes of liposomes. The values of the protono-
phore-dependent potentials detected in the presence
of doxorubicin are negligible (data not shown),
therefore the membrane permeability of doxorubicin
is obviously considerably lower than that of ace-
tate.
3.4. E¡ect of pluronics on the transfer of
tetraphenylborate across lipid bilayers
As shown earlier, the application of a voltage
jump to the BLM in the presence of permeating
anions (TPB3) results in a current relaxation kinetics
with a steady-state current substantially less than the
initial current [44,48]. This kinetics can be accounted
for by the model assuming that the rate constant of
the translocation of the permeating anions across the
BLM substantially exceeds those of their association
with or dissociation from the BLM. Therefore, the
initial transmembrane current vanishes after the de-
pletion of TPB3 anions on one side of the membrane
due to translocation of the major part of the anions
to the opposite side [44]. The number of coulombs
moving through the bilayer during a single current
transient (Q) corresponds to the total number of
TPB3 anions transferred through the BLM. The
characteristic time (d) of TPB3 translocation was
Fig. 6. E¡ect of P85 pluronic copolymer (5U1034%) on the
TPB-induced current transient after the application of a voltage
jump (100 mV) to the BLM (curve 2). Curve 1 is a control
without P85, it is well ¢tted by a single exponential with I0 = 30
nA and d= 83 ms. Curve 2 is ¢tted by a single exponential with
I0 = 120 nA and d= 7.5 ms. The solution is 10 mM Tris, 10
mM MES, 100 mM choline chloride, pH 6.4. TPB3 concentra-
tion is 1 WM. (Inset) Filtered traces of curves 1 and 2 at the
end of the recordings.
Fig. 5. (A) E¡ect of L61 pluronic copolymer (1U1032%) on the
£ux of acetic acid (50 WM on the cis side of the BLM) across
the planar bilayer measured by the recording of transmembrane
vpH (acidi¢cation on the trans side). The conditions are the
same as in Fig. 1, pH 6.3. (B) E¡ect of P85 pluronic copolymer
(2U1032%) on the £ux of ammonia (100 WM on the cis side of
the BLM) across the planar bilayer measured by the recording
of transmembrane vpH (acidi¢cation on the cis side). The con-
ditions are the same as in Fig. 1, pH 6.5.
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83 ms in our experiments (Fig. 6, curve 1). The ad-
dition of 5U1034% of P85 copolymer resulted in an
11-fold decrease in the value of d and a four-fold
increase in the initial current (Fig. 6, curve 2). The
corresponding ¢rst order constant (k = 1/d) increased
from 12 s31 to 133 s31. The number of coulombs
transferred across the BLM, calculated as an inte-
gral,
Q 
Z r
0
Itdt;
also displayed a 2.2-fold decrease indicating that
pluronic adsorption on the BLM reduced the
amount of membrane-bound TPB3.
The relaxation of the current resulted in a low
but de¢nite steady-state level determined presumably
by the rates of TPB3 adsorption/desorption kinetics
(inset in Fig. 6). It is seen that the addition of
pluronic L61 did not alter the steady-state current
showing that the pluronic selectively a¡ects the stage
of TPB3 translocation across the membrane. Fig. 7
shows the concentration dependence of the copoly-
mer’s e¡ect on the TPB3 translocation rate constant
(panel A) and the amount of transferred TPB3 (elec-
trical charges in nC) upon the voltage jump (panel
B). The translocation rate increases with the copoly-
mer concentration indicating that the e¡ect is medi-
ated by polymer adsorption on the BLM.
It is worth noting that pluronic copolymers also
increased the valinomycin-mediated K electrical
conductance (by about 30% at a BLM conductance
similar to that mentioned above in the experiments
with TPB3). Therefore, the e¡ect of pluronic copoly-
mers is not accounted for by the change in the dipole
potential of the membrane, since the increase in the
dipole potential should accelerate the translocation
of anions but decrease the translocation rate of cat-
ions [49,50].
We compared the e¡ect of di¡erent pluronic co-
polymers and the polyethylene oxide (PEO)-contain-
ing detergent Triton X-100 (p-iso-octylphenyl mono-
ether of PEO (n = 10)) at a ¢xed copolymer
concentration (Table 1). It may be concluded that
the increase in copolymer hydrophobicity and the
portion of the propylene oxide (PPO) units in the
pluronic molecule enhances the e¡ect on TPB trans-
location. At the same time, the duration of the PEO
block mainly determines the copolymer e¡ect on the
Q value, probably via the in£uence on the membrane
area covered with PEO chains.
3.5. E¡ect of pluronics on the doxorubicin in£ux into
liposomes
Following Harrigan et al. [40] and Maurer-Spurej
et al. [46] our experimental model of doxorubicin
transport is based on the accumulation of doxorubi-
cin in response to the pH gradient formed on lipo-
Fig. 7. The dependence of the translocation rate constant of
TPB3 (A) and the magnitude of the transferred charges (B) on
the concentration of P85 pluronic copolymer. TPB3 concentra-
tion is 1 WM. Other conditions are the same as in Fig. 6.
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some membranes (pH = 4 inside and 7 outside). Dox-
orubicin is a weak base which binds proton under
acidic conditions; it is unable to permeate through
the membrane in the charged form. The in£ux of
doxorubicin into liposomes leads to an increase in
its local concentration inside liposomes, which results
in a decrease in the drug’s £uorescence due to self-
quenching [40].
Fig. 8 shows the kinetics of the doxorubicin up-
take into liposomes in the absence (curve 1) and in
the presence of 3.6U1033% L61 pluronic (curve 2).
Both curves are single exponential, so the simple ¢rst
order model describes well the uptake kinetics. The
addition of L61 pluronic resulted in an about three-
fold acceleration of doxorubicin transport across the
liposome membrane. The increase in the L61 plur-
onic concentration resulted in a gradual increase in
doxorubicin uptake (Fig. 9). At the high pluronic
concentration the rate constant becomes eight times
higher than that in the control.
The pH dependence of the kinetic constants of
drug uptake into liposomes gives information on
the mechanism of the action of the pluronic on doxo-
rubicin transport. If the permeation of doxorubicin
is limited by the transfer of the neutral form across
the bilayer, a reduction of the external bu¡er pH
should result in a decrease of in£ux rate due to a
lowering of the neutral form content in the external
bu¡er. This dependence is observed in the experi-
ment shown in Fig. 10 (curve 1). The same pH de-
pendence was observed in the presence of pluronic
L61, showing that the pluronic facilitates the uptake
of the neutral form of doxorubicin (Fig. 10, curve 2).
Variation of the duration of PEO and PPO blocks
in the pluronic molecule results in drastic alterations
of its properties [51^53]. An increase of the PPO/
PEO ratio in the copolymer molecule leads to a de-
crease of its CMC (Table 1), water solubility and a
change of micellar structure. It is reasonable to sug-
Fig. 10. pH dependence of the ¢rst order rate constant of doxo-
rubicin uptake into liposomes in the presence (curve 2) and in
the absence of pluronic copolymers. The conditions are the
same as in Fig. 8.
Fig. 9. The dependence of the ¢rst order rate constant of doxo-
rubicin uptake into liposomes on pluronic L61 concentration.
The conditions are the same as in Fig. 8.
Fig. 8. E¡ect of the pluronic copolymer on the kinetics of the
pH gradient-induced uptake of doxorubicin into liposomes.
Curve 1 is a control, and curve 2 is 3.6U1033% L61. Internal
bu¡er contains 0.3 M citrate, pH 4.0, external bu¡er contains
20 mM HEPES, 5 mM Tris, 0.27 M sucrose, pH 7.0.
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gest that more hydrophobic pluronics containing
more PPO units will cause stronger e¡ects on the
membrane structure than hydrophilic ones. A com-
parison of the therapeutic e¡ects of di¡erent plur-
onics in combination with doxorubicin [21] has
shown that more hydrophobic pluronics (L61, P85)
are substantially more e¡ective than hydrophilic co-
polymers (F68, Table 1). In our experiments with
doxorubicin in£ux into liposomes, the more hydro-
phobic pluronics L61 and P85 caused more pro-
nounced changes in £ux than the hydrophilic copoly-
mer F68. The same correlation was observed for the
transport of TPB3 (Table 1). The correlation of op-
timal therapeutic concentrations of the pluronics and
the e¡ect on doxorubicin in£ux indicates that the
e¡ect of pluronic copolymers on the permeability
of the lipid bilayer is important for their biological
activity.
Taking into account that the PEO/PPO ratio cor-
relates with the ability of the copolymer to form
micelles in a water solution (Table 1), one may sup-
pose that the e¡ect of pluronics on lipid membrane
permeability is somehow related to their surface ac-
tivity. In order to examine this assumption, we
studied the e¡ect of Triton X-100 containing the al-
kyl radical in its hydrophobic block. It turned out
that Triton X-100 has a negligible e¡ect on doxoru-
bicin transport across liposome membrane, when
added at a concentration of 4U1033% (Table 1).
The addition of Triton X-100 at higher concentra-
tions led to leakage of bu¡er components from a
portion of the liposomes. At the same time the doxo-
rubicin in£ux rate measured by £uorescence intensity
was a¡ected only slightly. Thus, the surface activity
of pluronic copolymers is not the only factor that
determines its in£uence on bilayer permeability. De-
tergents with hydrocarbons in their hydrophobic
blocks exhibit quite di¡erent behavior.
4. Discussion
In a series of papers [17^19,54] pluronic copoly-
mers have been reported to promote permeation of
water-soluble drugs across cell membranes. This ef-
fect was attributed to the pluronic copolymer-medi-
ated inhibition of the multidrug resistance protein
[21^23]. The present results show that pluronic co-
polymers can accelerate the permeation of di¡erent
solutes across the lipid part of biological membranes.
The process of permeation across lipid membranes
includes the adsorption of a solute on the membrane,
the translocation through the hydrophobic region of
the lipid bilayer and the desorption from the mem-
brane. The total permeability value PM depends on
the rate constants of these processes as proposed, for
example, by Miller [55] :
PM  kWLkTkLW  2kT 4
where kWL is the rate constant of solute translocation
from the water phase to the lipid bilayer, kLW is the
rate constant of its translocation from the lipid bi-
layer to the water solution and kT is the rate constant
of the di¡usion of the solute across the membrane.
Since pluronic copolymers are widely used to facili-
tate the incorporation of hydrophobic compounds
into membranes (see, for example, [56]) the increase
in membrane permeability caused by pluronics may
be attributed to the in£uence on the kWL and kLW
constants. However, the results of the experiments
with TPB3 show that pluronics increase the kT value
of TPB3. Moreover, steady-state current measure-
ments in the presence of TPB3 indicate that plur-
onics do not alter the kLW and kWL values. These
results support the idea that the action of pluronic
copolymers on membrane permeability proceeds via
the e¡ect on inner membrane di¡usion.
Therefore, the selectivity of pluronic action on the
transport of di¡erent substances is probably caused
by the di¡erent mechanisms of solute permeability in
the membrane interior. In fact, ammonia and acetic
acid are comparatively small molecules and their per-
meation can proceed at least partially via membrane
microdefects. On the other hand, the permeation of
K,K-DC11 or doxorubicin can hardly proceed via the
above mentioned process and apparently goes via the
solubility^di¡usion mechanism.
Another possible mechanism of the selective e¡ect
of pluronics may be associated with the dependence
of the process of the transmembrane di¡usion of
solutes on the size and/or the form of the molecules
[34,57,58]. It was shown that the membrane interior
can hardly be regarded as a classical liquid [59] and
that permeant di¡usion is strongly dependent on its
shape and size. Thus, the selective action of pluronics
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may be accounted for by their disturbance of bilayer
lipid packing which mediates the process of solute
permeation in the case of large molecules. This con-
clusion is in line with the recent ¢nding that plur-
onics can lower the membrane microviscosity of plas-
ma membranes of tumor cells [60].
As discussed above, it seems unlikely that plur-
onics form channels or hydrated pores in the BLM.
If so, pluronics should increase the planar bilayer
electrical conductivity. Besides, we observed that
the permeation of small hydrophilic acids
(CH3COOH) and bases (NH3) is not a¡ected by
pluronic, while the £ux of large molecules (K,K-
DC11 and doxorubicin) is strongly increased in the
presence of pluronic copolymers. These ¢ndings also
contradict the channel mechanism of the e¡ect of
pluronic copolymers. Thus, the action of pluronics
di¡ers from that of commonly used permeabilizers
[1^5].
Importantly, the e¡ect of pluronic copolymers on
membrane permeability is quite di¡erent from that of
conventional detergents such as Triton X-100 that
also contain PEO groups. The addition of Triton
X-100 at low concentrations (similar to that of plur-
onics) has no e¡ect on the doxorubicin pH-induced
uptake into liposomes, while the increase in the de-
tergent concentration results in leakage of liposomes
and complete inhibition of the pH-induced drug up-
take. We suppose that peculiarities of the action of
pluronics in comparison with traditional PEO-con-
taining detergents are caused by the structure of
the hydrophobic PPO block that contains polar oxy-
gen groups. Since the overall hydrophobicity of the
PPO block is rather high, it binds to the apolar part
of the lipid bilayer [25]. However, oxygen atoms
placed in the hydrophobic environment can disturb
it. Apparently, this disturbance mainly determines
the action of the copolymer on the membrane per-
meability.
We suppose that the e¡ect of the pluronic on doxo-
rubicin permeation across lipid bilayers provides
the basis for its in£uence on the therapeutic activity
of anthracycline drugs. Measurements of the phar-
macokinetics of pluronics in mice have shown that
their concentration in the bloodstream remains at a
level of 5U1033^5U1034% for several hours after
injection of therapeutic doses of the copolymer [21].
Our results demonstrate that such copolymer concen-
trations can considerably accelerate drug permeation
across the lipid part of the plasma membrane of
cells.
In a series of recent publications [21^23] pluronic
copolymers have been shown to increase the sensitiv-
ity of multidrug-resistant (MDR) cells with respect to
various chemotherapeutic agents, such as anthracy-
clines, Vinca alkaloids, and others. In the presence of
pluronics P85 and L61, the cytotoxic activity of the
drugs against MDR cells increased 100^1000 times,
whereas only marginal changes in the drugs’ cytotox-
icity were observed in the case of sensitive cells [21^
23]. It was shown that pluronic copolymers facilitate
accumulation of doxorubicin in the resistant cells,
the e⁄cacy of their action being dependent on the
expression of the MDR phenotype. It was suggested
that pluronic copolymers stimulate drug accumula-
tion in the cell cytoplasm by inhibiting the P-glyco-
protein-mediated drug e¥ux from the resistant cells.
The results of the present paper suggest that along
with the above proposed mechanism an additional
e¡ect of pluronic copolymers can take place. In
fact, copolymer adsorption on the cell plasma mem-
brane accelerates doxorubicin translocation across
the lipid parts of the membrane and should facilitate
its accumulation in the cytoplasm. According to the
¢ndings presented above, this will allow the drug to
bypass P-glycoprotein located in the plasma mem-
brane of resistant cells. The reduced e¡ect of plur-
onic copolymers on sensitive cells may be accounted
for by the dependence of the e¡ect on the lipid com-
position of cell membranes. We suppose that the
study of the in£uence of pluronics on the transport
of di¡erent substances across lipid bilayers will be
important for the elaboration of pluronic-based
drug formulations.
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